Skip to main content
Top
Published in: Obesity Surgery 7/2021

Open Access 01-07-2021 | Sleeve Gastrectomy | Original Contributions

Comparison of Liver Recovery After Sleeve Gastrectomy and Roux-en-Y-Gastric Bypass

Authors: Sophia M.-T. Schmitz, Andreas Kroh, Alexander Koch, Jonathan F. Brozat, Christine Stier, Ulf P. Neumann, Tom F. Ulmer, Patrick H. Alizai

Published in: Obesity Surgery | Issue 7/2021

Login to get access

Abstract

Background

Nonalcoholic fatty liver disease (NAFLD) is a common condition in patients with obesity. Bariatric surgery has often been proposed as a viable treatment option, but the ideal surgical procedure remains unclear. Inconsistently, reports on postoperative deterioration of liver function put further doubt on which technique to apply. Aim of this study was to assess the impact of Roux-en-Y-gastric bypass (RYGB) and sleeve gastrectomy (SG) on the postoperative recovery of liver function.

Methods

A total of 175 patients with obesity that underwent bariatric surgery in our institution were included in this prospective cohort study. BMI, laboratory values, and liver function capacity (using LiMAx) were assessed preoperatively and at 6 and 12 months postoperatively. Generalized linear model (GLM) was performed to determine variables influencing liver function capacity after the operation.

Results

Prior to operations, 64% of patients presented with a diminished liver function capacity, as measured by LiMAx test. Liver function capacity significantly recovered after 12 months in the SG group (300 μg/kg/h preop vs. 367 μg/kg/h postop) but not in the RYGB group (306 μg/kg/h preop vs. 349 μg/kg/h). Preoperative factors impeding liver function recovery included type 2 diabetes mellitus (T2DM), weight, male sex, AST/thrombocyte ratio (APRI), and gamma-glutamyltransferase (GGT).

Conclusion

Bariatric surgery, especially sleeve gastrectomy, leads to an improvement of liver function. However, in some patients with T2DM, higher preoperative weight and male sex postoperative deterioration of liver function capacity may occur.

Graphical abstract

Literature
1.
go back to reference Younossi ZM. Non-alcoholic fatty liver disease—a global public health perspective. J Hepatol. 2019;70(3):531–44.PubMedCrossRef Younossi ZM. Non-alcoholic fatty liver disease—a global public health perspective. J Hepatol. 2019;70(3):531–44.PubMedCrossRef
2.
go back to reference Otgonsuren M, Stepanova M, Gerber L, et al. Anthropometric and clinical factors associated with mortality in subjects with nonalcoholic fatty liver disease. Dig Dis Sci. 2013;58(4):1132–40.PubMedCrossRef Otgonsuren M, Stepanova M, Gerber L, et al. Anthropometric and clinical factors associated with mortality in subjects with nonalcoholic fatty liver disease. Dig Dis Sci. 2013;58(4):1132–40.PubMedCrossRef
3.
go back to reference Younossi Z, Anstee QM, Marietti M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15(1):11–20.PubMedCrossRef Younossi Z, Anstee QM, Marietti M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15(1):11–20.PubMedCrossRef
4.
go back to reference Souto KP, Meinhardt NG, Ramos MJ, et al. Nonalcoholic fatty liver disease in patients with different baseline glucose status undergoing bariatric surgery: analysis of intraoperative liver biopsies and literature review. Surg Obes Relat Dis. 2018;14(1):66–73.PubMedCrossRef Souto KP, Meinhardt NG, Ramos MJ, et al. Nonalcoholic fatty liver disease in patients with different baseline glucose status undergoing bariatric surgery: analysis of intraoperative liver biopsies and literature review. Surg Obes Relat Dis. 2018;14(1):66–73.PubMedCrossRef
5.
go back to reference Waits SA, Sheetz KH, Ghaferi AA. Considering bariatric surgery in patients with nonalcoholic steatohepatitis-worth the risk. JAMA Netw Open. 2019;2(2):e190053.PubMedCrossRef Waits SA, Sheetz KH, Ghaferi AA. Considering bariatric surgery in patients with nonalcoholic steatohepatitis-worth the risk. JAMA Netw Open. 2019;2(2):e190053.PubMedCrossRef
6.
go back to reference Lee Y, Doumouras AG, Yu J, et al. Complete resolution of nonalcoholic fatty liver disease after bariatric surgery: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2019;17(6):1040–60. e11PubMedCrossRef Lee Y, Doumouras AG, Yu J, et al. Complete resolution of nonalcoholic fatty liver disease after bariatric surgery: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2019;17(6):1040–60. e11PubMedCrossRef
7.
go back to reference Mathurin P, Hollebecque A, Arnalsteen L, et al. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology. 2009;137(2):532–40.PubMedCrossRef Mathurin P, Hollebecque A, Arnalsteen L, et al. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology. 2009;137(2):532–40.PubMedCrossRef
8.
go back to reference Alizai PH, Wendl J, Roeth AA, et al. Functional liver recovery after bariatric surgery—a prospective cohort study with the LiMAx test. Obes Surg. 2015;25(11):2047–53.PubMedCrossRef Alizai PH, Wendl J, Roeth AA, et al. Functional liver recovery after bariatric surgery—a prospective cohort study with the LiMAx test. Obes Surg. 2015;25(11):2047–53.PubMedCrossRef
9.
go back to reference Mummadi RR, Kasturi KS, Chennareddygari S, et al. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2008;6(12):1396–402.PubMedCrossRef Mummadi RR, Kasturi KS, Chennareddygari S, et al. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2008;6(12):1396–402.PubMedCrossRef
10.
go back to reference Wirth KM, Sheka AC, Kizy S, et al. Bariatric surgery is associated with decreased progression of nonalcoholic fatty liver disease to cirrhosis: a retrospective cohort analysis. Ann Surg. 2020;272(1):32–9.PubMedCrossRef Wirth KM, Sheka AC, Kizy S, et al. Bariatric surgery is associated with decreased progression of nonalcoholic fatty liver disease to cirrhosis: a retrospective cohort analysis. Ann Surg. 2020;272(1):32–9.PubMedCrossRef
11.
go back to reference Burza MA, Romeo S, Kotronen A, et al. Long-term effect of bariatric surgery on liver enzymes in the Swedish Obese Subjects (SOS) study. PLoS One. 2013;8(3):e60495.PubMedPubMedCentralCrossRef Burza MA, Romeo S, Kotronen A, et al. Long-term effect of bariatric surgery on liver enzymes in the Swedish Obese Subjects (SOS) study. PLoS One. 2013;8(3):e60495.PubMedPubMedCentralCrossRef
12.
go back to reference Baldwin D, Chennakesavalu M, Gangemi A. Systematic review and meta-analysis of Roux-en-Y gastric bypass against laparoscopic sleeve gastrectomy for amelioration of NAFLD using four criteria. Surg Obes Relat Dis. 2019;15(12):2123–30.PubMedCrossRef Baldwin D, Chennakesavalu M, Gangemi A. Systematic review and meta-analysis of Roux-en-Y gastric bypass against laparoscopic sleeve gastrectomy for amelioration of NAFLD using four criteria. Surg Obes Relat Dis. 2019;15(12):2123–30.PubMedCrossRef
13.
go back to reference von Schonfels W, Beckmann JH, Ahrens M, et al. Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS (NAFLD activity score). Surg Obes Relat Dis. 2018;14(10):1607–16.CrossRef von Schonfels W, Beckmann JH, Ahrens M, et al. Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS (NAFLD activity score). Surg Obes Relat Dis. 2018;14(10):1607–16.CrossRef
14.
go back to reference Salman MA, Salman AA, Abdelsalam A, et al. Laparoscopic sleeve gastrectomy on the horizon as a promising treatment modality for NAFLD. Obes Surg. 2020;30(1):87–95.PubMedCrossRef Salman MA, Salman AA, Abdelsalam A, et al. Laparoscopic sleeve gastrectomy on the horizon as a promising treatment modality for NAFLD. Obes Surg. 2020;30(1):87–95.PubMedCrossRef
15.
go back to reference Froylich D, Corcelles R, Daigle C, et al. Effect of Roux-en-Y gastric bypass and sleeve gastrectomy on nonalcoholic fatty liver disease: a comparative study. Surg Obes Relat Dis. 2016;12(1):127–31.PubMedCrossRef Froylich D, Corcelles R, Daigle C, et al. Effect of Roux-en-Y gastric bypass and sleeve gastrectomy on nonalcoholic fatty liver disease: a comparative study. Surg Obes Relat Dis. 2016;12(1):127–31.PubMedCrossRef
16.
go back to reference Koh ZJ, Salgaonkar HP, Lee WJJ, et al. Improvement in non-alcoholic fatty liver disease score correlates with weight loss in obese patients undergoing laparoscopic sleeve gastrectomy: a two-centre study from an Asian cohort. Obes Surg. 2019;29(3):862–8.PubMedCrossRef Koh ZJ, Salgaonkar HP, Lee WJJ, et al. Improvement in non-alcoholic fatty liver disease score correlates with weight loss in obese patients undergoing laparoscopic sleeve gastrectomy: a two-centre study from an Asian cohort. Obes Surg. 2019;29(3):862–8.PubMedCrossRef
17.
go back to reference Borges-Canha M, Neves JS, Mendonca F, et al. The impact of bariatric surgery on hepatic function and predictors of liver steatosis and fibrosis. Obes Surg. 2020;30(8):2935–41.PubMedCrossRef Borges-Canha M, Neves JS, Mendonca F, et al. The impact of bariatric surgery on hepatic function and predictors of liver steatosis and fibrosis. Obes Surg. 2020;30(8):2935–41.PubMedCrossRef
18.
go back to reference Vespasiani-Gentilucci U, Vorini F, Carotti S, et al. Hepatic complications of bariatric surgery: the reverse side of the coin. Acta Gastro-Enterol Belg. 2017;80(4):505–13. Vespasiani-Gentilucci U, Vorini F, Carotti S, et al. Hepatic complications of bariatric surgery: the reverse side of the coin. Acta Gastro-Enterol Belg. 2017;80(4):505–13.
19.
go back to reference Kalinowski P, Paluszkiewicz R, Ziarkiewicz-Wroblewska B, et al. Liver function in patients with nonalcoholic fatty liver disease randomized to Roux-en-Y gastric bypass versus sleeve gastrectomy: a secondary analysis of a randomized clinical trial. Ann Surg. 2017;266(5):738–45.PubMedCrossRef Kalinowski P, Paluszkiewicz R, Ziarkiewicz-Wroblewska B, et al. Liver function in patients with nonalcoholic fatty liver disease randomized to Roux-en-Y gastric bypass versus sleeve gastrectomy: a secondary analysis of a randomized clinical trial. Ann Surg. 2017;266(5):738–45.PubMedCrossRef
20.
go back to reference Nickel F, Tapking C, Benner L, et al. Bariatric surgery as an efficient treatment for non-alcoholic fatty liver disease in a prospective study with 1-year follow-up: BariScan study. Obes Surg. 2018;28(5):1342–50.PubMedCrossRef Nickel F, Tapking C, Benner L, et al. Bariatric surgery as an efficient treatment for non-alcoholic fatty liver disease in a prospective study with 1-year follow-up: BariScan study. Obes Surg. 2018;28(5):1342–50.PubMedCrossRef
21.
go back to reference Billeter AT, Senft J, Gotthardt D, et al. Combined non-alcoholic fatty liver disease and type 2 diabetes mellitus: sleeve gastrectomy or gastric bypass?—a controlled matched pair study of 34 patients. Obes Surg. 2016;26(8):1867–74.PubMedCrossRef Billeter AT, Senft J, Gotthardt D, et al. Combined non-alcoholic fatty liver disease and type 2 diabetes mellitus: sleeve gastrectomy or gastric bypass?—a controlled matched pair study of 34 patients. Obes Surg. 2016;26(8):1867–74.PubMedCrossRef
22.
23.
24.
go back to reference Schwimmer JB, Behling C, Angeles JE, et al. Magnetic resonance elastography measured shear stiffness as a biomarker of fibrosis in pediatric nonalcoholic fatty liver disease. Hepatology. 2017;66(5):1474–85.PubMedPubMedCentralCrossRef Schwimmer JB, Behling C, Angeles JE, et al. Magnetic resonance elastography measured shear stiffness as a biomarker of fibrosis in pediatric nonalcoholic fatty liver disease. Hepatology. 2017;66(5):1474–85.PubMedPubMedCentralCrossRef
25.
go back to reference Cherla DV, Rodriguez NA, Vangoitsenhoven R, Singh T, Mehta N, McCullough AJ, et al. Impact of sleeve gastrectomy and Roux-en-Y gastric bypass on biopsy-proven non-alcoholic fatty liver disease. Surg Endosc 2019. Cherla DV, Rodriguez NA, Vangoitsenhoven R, Singh T, Mehta N, McCullough AJ, et al. Impact of sleeve gastrectomy and Roux-en-Y gastric bypass on biopsy-proven non-alcoholic fatty liver disease. Surg Endosc 2019.
26.
go back to reference Perysinakis I, Pappis HC, Margaris E. Current controversies in metabolic surgery for nonalcoholic fatty liver disease. Obes Surg. 2019;29(3):1058–67.PubMedCrossRef Perysinakis I, Pappis HC, Margaris E. Current controversies in metabolic surgery for nonalcoholic fatty liver disease. Obes Surg. 2019;29(3):1058–67.PubMedCrossRef
27.
go back to reference Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55(6):2005–23.PubMedCrossRef Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55(6):2005–23.PubMedCrossRef
28.
go back to reference Mahawar KK, Parmar C, Graham Y, et al. Monitoring of liver function tests after Roux-en-Y gastric bypass: an examination of evidence base. Obes Surg. 2016;26(10):2516–22.PubMedCrossRef Mahawar KK, Parmar C, Graham Y, et al. Monitoring of liver function tests after Roux-en-Y gastric bypass: an examination of evidence base. Obes Surg. 2016;26(10):2516–22.PubMedCrossRef
29.
go back to reference Mumtaz K, Lipshultz H, Jalil S, et al. Bariatric surgery in patients with cirrhosis: careful patient and surgery-type selection is key to improving outcomes. Obes Surg. 2020;30(9):3444–52.PubMedCrossRef Mumtaz K, Lipshultz H, Jalil S, et al. Bariatric surgery in patients with cirrhosis: careful patient and surgery-type selection is key to improving outcomes. Obes Surg. 2020;30(9):3444–52.PubMedCrossRef
30.
go back to reference Schmitz SM, Kroh A, Ulmer TF, et al. Evaluation of NAFLD and fibrosis in obese patients—a comparison of histological and clinical scoring systems. BMC Gastroenterol. 2020;20(1):254.PubMedPubMedCentralCrossRef Schmitz SM, Kroh A, Ulmer TF, et al. Evaluation of NAFLD and fibrosis in obese patients—a comparison of histological and clinical scoring systems. BMC Gastroenterol. 2020;20(1):254.PubMedPubMedCentralCrossRef
31.
32.
go back to reference Stockmann M, Lock JF, Malinowski M, et al. The LiMAx test: a new liver function test for predicting postoperative outcome in liver surgery. HPB (Oxford). 2010;12(2):139–46.CrossRef Stockmann M, Lock JF, Malinowski M, et al. The LiMAx test: a new liver function test for predicting postoperative outcome in liver surgery. HPB (Oxford). 2010;12(2):139–46.CrossRef
33.
go back to reference Lock JF, Malinowski M, Seehofer D, et al. Function and volume recovery after partial hepatectomy: influence of preoperative liver function, residual liver volume, and obesity. Langenbeck's Arch Surg. 2012;397(8):1297–304.CrossRef Lock JF, Malinowski M, Seehofer D, et al. Function and volume recovery after partial hepatectomy: influence of preoperative liver function, residual liver volume, and obesity. Langenbeck's Arch Surg. 2012;397(8):1297–304.CrossRef
34.
go back to reference Praveen Raj P, Gomes RM, Kumar S, et al. The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: “NASHOST” prospective observational trial. Surg Obes Relat Dis. 2015;11(6):1315–22.PubMedCrossRef Praveen Raj P, Gomes RM, Kumar S, et al. The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: “NASHOST” prospective observational trial. Surg Obes Relat Dis. 2015;11(6):1315–22.PubMedCrossRef
35.
go back to reference James AW, Rabl C, Westphalen AC, et al. Portomesenteric venous thrombosis after laparoscopic surgery: a systematic literature review. Arch Surg. 2009;144(6):520–6.PubMedCrossRef James AW, Rabl C, Westphalen AC, et al. Portomesenteric venous thrombosis after laparoscopic surgery: a systematic literature review. Arch Surg. 2009;144(6):520–6.PubMedCrossRef
36.
go back to reference Moon RC, Ghanem M, Teixeira AF, et al. Assessing risk factors, presentation, and management of portomesenteric vein thrombosis after sleeve gastrectomy: a multicenter case-control study. Surg Obes Relat Dis. 2018;14(4):478–83.PubMedCrossRef Moon RC, Ghanem M, Teixeira AF, et al. Assessing risk factors, presentation, and management of portomesenteric vein thrombosis after sleeve gastrectomy: a multicenter case-control study. Surg Obes Relat Dis. 2018;14(4):478–83.PubMedCrossRef
37.
go back to reference Goitein D, Matter I, Raziel A, et al. Portomesenteric thrombosis following laparoscopic bariatric surgery: incidence, patterns of clinical presentation, and etiology in a bariatric patient population. JAMA Surg. 2013;148(4):340–6.PubMedCrossRef Goitein D, Matter I, Raziel A, et al. Portomesenteric thrombosis following laparoscopic bariatric surgery: incidence, patterns of clinical presentation, and etiology in a bariatric patient population. JAMA Surg. 2013;148(4):340–6.PubMedCrossRef
38.
go back to reference Garcia-Sesma A, Calvo J, Manrique A, et al. Morbidly obese patients awaiting liver transplantation-sleeve gastrectomy: safety and efficacy from a liver transplant unit experience. Transplant Proc. 2019;51(1):33–7.PubMedCrossRef Garcia-Sesma A, Calvo J, Manrique A, et al. Morbidly obese patients awaiting liver transplantation-sleeve gastrectomy: safety and efficacy from a liver transplant unit experience. Transplant Proc. 2019;51(1):33–7.PubMedCrossRef
39.
go back to reference Jan A, Narwaria M, Mahawar KK. A systematic review of bariatric surgery in patients with liver cirrhosis. Obes Surg. 2015;25(8):1518–26.PubMedCrossRef Jan A, Narwaria M, Mahawar KK. A systematic review of bariatric surgery in patients with liver cirrhosis. Obes Surg. 2015;25(8):1518–26.PubMedCrossRef
40.
41.
go back to reference Klebanoff MJ, Corey KE, Samur S, et al. Cost-effectiveness analysis of bariatric surgery for patients with nonalcoholic steatohepatitis cirrhosis. JAMA Netw Open. 2019;2(2):e190047.PubMedPubMedCentralCrossRef Klebanoff MJ, Corey KE, Samur S, et al. Cost-effectiveness analysis of bariatric surgery for patients with nonalcoholic steatohepatitis cirrhosis. JAMA Netw Open. 2019;2(2):e190047.PubMedPubMedCentralCrossRef
42.
go back to reference Samuel N, Jalal Q, Gupta A, et al. Mid-term bariatric surgery outcomes for obese patients: does weight matter? Ann R Coll Surg Engl. 2020;102(1):54–61.PubMedCrossRef Samuel N, Jalal Q, Gupta A, et al. Mid-term bariatric surgery outcomes for obese patients: does weight matter? Ann R Coll Surg Engl. 2020;102(1):54–61.PubMedCrossRef
43.
go back to reference Diaz-Tobarra M, Cassinello Fernandez N, Jorda Gomez P, et al. One-stage vs two-stage laparoscopic Roux-en-Y gastric bypass in obese patients with body mass index >55 kg/m(2); 5-year follow up. Obes Surg. 2017;27(4):955–60.PubMedCrossRef Diaz-Tobarra M, Cassinello Fernandez N, Jorda Gomez P, et al. One-stage vs two-stage laparoscopic Roux-en-Y gastric bypass in obese patients with body mass index >55 kg/m(2); 5-year follow up. Obes Surg. 2017;27(4):955–60.PubMedCrossRef
44.
go back to reference Xiao G, Zhu S, Xiao X, et al. Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis. Hepatology. 2017;66(5):1486–501.PubMedCrossRef Xiao G, Zhu S, Xiao X, et al. Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis. Hepatology. 2017;66(5):1486–501.PubMedCrossRef
45.
go back to reference Tapper EB, Loomba R. Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD. Nat Rev Gastroenterol Hepatol. 2018;15(5):274–82.PubMedPubMedCentralCrossRef Tapper EB, Loomba R. Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD. Nat Rev Gastroenterol Hepatol. 2018;15(5):274–82.PubMedPubMedCentralCrossRef
Metadata
Title
Comparison of Liver Recovery After Sleeve Gastrectomy and Roux-en-Y-Gastric Bypass
Authors
Sophia M.-T. Schmitz
Andreas Kroh
Alexander Koch
Jonathan F. Brozat
Christine Stier
Ulf P. Neumann
Tom F. Ulmer
Patrick H. Alizai
Publication date
01-07-2021
Publisher
Springer US
Published in
Obesity Surgery / Issue 7/2021
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-021-05390-1

Other articles of this Issue 7/2021

Obesity Surgery 7/2021 Go to the issue